Physician profile
Batsheva Kramer
NPI 1730270612
$1,761.18
in general payments reported to CMS, 2019-2025
26 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $402 · 2022: $241 · 2023: $538 · 2024: $284 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,117.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $307.45 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $173.17 | 2022-2025 | Jardiance |
| Dexcom, INC. | $160.00 | 2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Lilly USA, LLC | $151.18 | 2021-2024 | Jardiance, Kisunla, Amyvid |
| Genzyme Corporation | $150.76 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $146.36 | 2023-2025 | Vpriv |
| Csl Behring | $85.80 | 2022 | |
| Pfizer INC. | $80.73 | 2023-2024 | |
| Amneal Pharmaceuticals LLC | $70.79 | 2022-2023 | Unithroid |
| Xeris Pharmaceuticals, INC. | $55.81 | 2023-2025 | Gvoke Hypopen |
| Grt US Holding, INC. | $50.14 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $35.62 | 2021 | |
| Astellas Pharma US INC | $33.78 | 2024 | Veozah |
| Paratek Pharmaceuticals, INC. | $32.63 | 2023 | Nuzyra |
| Vertex Pharmaceuticals Incorporated | $29.80 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $25.31 | 2025 | Farxiga |
| Sanofi Pasteur INC. | $21.11 | 2023 | |
| Eisai INC. | $19.23 | 2024 | |
| Hologic Sales and Service, LLC | $17.97 | 2024 | Aptima |
| Alk-Abello, INC | $17.32 | 2023 | Odactra, Grastek |
| Idorsia Pharmaceuticals US INC | $16.67 | 2023 | Quviviq |
| Antares Pharma, INC. | $16.49 | 2023 | Xyosted, Tlando, Nocdurna |
| Biohaven Pharmaceutical Holding Company LTD. | $16.26 | 2022 | |
| Almatica Pharma LLC | $16.24 | 2021 | |
| Exact Sciences Corporation | $15.59 | 2024 | Cologuard Collection Kit |
| Abbvie INC. | $14.97 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Batsheva Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.